OakChart

Guardian Pharmacy Services Inc

GRDNHealthcare·Medical Care Facilities·USA·Mid·NYSE·Nov 11 • 12:42 PM ET

50.05+0.20 (0.40%)
2026-11-11 18:42 CET
Market cap
3,158.19 USD m
Revenue, TTM
1,457.05 USD m
Net income, TTM
74.77 USD m
Free cash flow, TTM
96.17 USD m
EPS diluted, TTM
1.17
P/E
42.69
Compare

Price

GRDN against its 20, 50 and 200-day averages
2050200beatearnings
30.0035.0040.0045.0050.001.6M3.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26GRDNclose 50.0520-day 41.5850-day 42.08200-day 38.6650.05

1.0% under the 52-week high of 50.54 on 11 Nov 2026. 52-week low 26.34 on 20 Jan 2026. Last 15 sessions, 30.1% high to low

Profile

GRDN
52-week range, 99% of the way up
26.3450.17

Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred P. Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.

IndexRUT
Employees3600
IPOSep 26, 2024
Beta-0.05
ATR, 14d2.06
Rel volume1.40
Short float8.23%
Insider own57.71%
Inst own46.67%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap3.17B
Enterprise Value3.10B
Income74.77M
Sales1.46B
Book/sh4.22
Cash/sh1.89
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees3600
IPOSep 26, 2024

Ratios

P/E42.69
Forward P/E33.46
PEG2.08
P/S2.18
P/B11.86
P/C26.50
P/FCF32.97
EV/EBITDA26.77
EV/Sales2.13
Quick Ratio1.33
Current Ratio1.65
Debt/Eq0.13
LT Debt/Eq0.10
Option/ShortYes / Yes

Earnings

EPS (ttm)1.17
EPS next Y1.50
EPS next Q0.45
EPS this Y27.50%
EPS next Y9.63%
EPS next 5Y16.07%
EPS past 3/5Y10.88% 31.17%
Sales past 3/5Y16.81% 16.29%
EPS Y/Y TTM83.17%
Sales Y/Y TTM4.85%
EPS Q/Q88.82%
Sales Q/Q-1.68%
EarningsNov 05 AMC
EPS/Sales Surpr.4.90% 1.45%

Ownership

Insider Own57.71%
Insider Trans0.00%
Inst Own46.67%
Inst Trans1.28%
ROA16.96%
ROE33.16%
ROIC25.33%
Gross Margin22.45%
Oper. Margin6.34%
Profit Margin5.13%
SMA2020.38%
SMA5018.93%
SMA20029.44%
Trades-

Technical

Shs Outstand63.32M
Shs Float26.79M
Short Float8.23%
Short Ratio4.13
Short Interest2.20M
52W High50.17 -0.24%
52W Low26.34 90.01%
Volatility8.20% 4.50%
ATR (14)2.06
RSI (14)73.31
Beta-0.05
Rel Volume1.40
Avg Volume534.14K
Volume388,248

Performance

Perf Week18.91%
Perf Month25.72%
Perf Quarter30.13%
Perf Half Y40.31%
Perf YTD66.33%
Perf Year60.16%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.14
Target Price50.14
Prev Close49.85
Price50.05
Change %0.40%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
Sep 23, 2026InitiatedKKeyBanc Capital MarketsOverweight$52+3.9%
Apr 27, 2026InitiatedBBofA SecuritiesBuy$42-16.1%
Mar 30, 2026InitiatedJJefferiesBuy$44-12.1%
Oct 10, 2025InitiatedOOppenheimerOutperform$30-40.1%
Oct 21, 2024InitiatedTTruistBuy$22-56.0%
Oct 21, 2024InitiatedRRaymond JamesOutperform$21-58.0%

Peers

Mkt cap
TickerCompanyMkt cap
BTSGBrightSpring Health Services Inc14.54B
OPCHOption Care Health Inc4.74B
BKDBrookdale Senior Living Inc2.20B
OMCLOmnicell Inc1.65B
ENSGEnsign Group Inc10.78B
CVSCVS Health Corp113.24B
CORCencora Inc66.26B
CAHCardinal Health Inc63.67B
CICigna Group78.28B
MCKMckesson Corp124.04B

Insider trading

10 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Pharmacy Investors, LLCMember of 10% owner groupMar 20 '26Sale29.68827,63624,566,3061,035,928Mar 24 04:15 PM
Morris David KSee RemarksMar 20 '26Sale29.68187,8555,576,006254,472Mar 24 04:15 PM
Burke FredSee RemarksMar 20 '26Sale29.68671,43219,929,780840,413Mar 24 04:15 PM
Forbes KendallSee RemarksMar 20 '26Sale29.68346,67210,290,092453,256Mar 24 04:15 PM
Cardinal Equity Fund, L.P.Member of 10% owner groupMar 20 '26Sale29.68275,7288,184,296345,123Mar 24 04:15 PM
Salentine Thomas J JrDirectorMar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 04:15 PM
Bindley Capital Partners I, LL10% OwnerMar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 04:15 PM
Ackerman JohnDirectorMar 20 '26Sale29.681,103,36432,750,602345,123Mar 24 04:15 PM
BINDLEY WILLIAM EDirectorMar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 04:15 PM
COSLER STEVEN DDirectorDec 03 '25Buy29.613,37099,78624,984Dec 05 04:10 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
FPXFirst Trust US Equity Opportunities ETFAUM: 1.34B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
DFMCU.S. Micro Cap Portfolio ETF Class Shares-

News

latest 14 of 180
  • Guardian Pharmacy Beats And Lifts EBITDA Outlook Again, But Management Signals The Margin Tailwind Will Fade (Earnings Whispers) -5.27% +6.32%
  • Guardian Pharmacy: Q3 Earnings Snapshot (Associated Press)
  • Guardian Pharmacy Services Acquires Vans Institutional Pharmacy, Expanding Footprint in Tennessee and Kentucky (Business Wire)
  • Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference (Business Wire)
  • Guardian Pharmacy's Q3 Test: Can Margins Keep Beating A Shrinking IRA-Hit Top Line? (Earnings Whispers)
  • Loading…
  • Guardian Pharmacy Services, Inc. to Report Third Quarter 2026 Financial Results and Host Conference Call (Business Wire) -6.90%
  • Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy (Business Wire)
  • Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference (Business Wire)
  • Guardian Pharmacy Services Raises 2026 Outlook After Strong Second Quarter (InvestorsHub) +11.05%
  • Guardian Pharmacy Services Inc (GRDN) (Q2 2026) Earnings Call Highlights: Raised Guidance and ... (GuruFocus.com)
  • Guardian Pharmacy: Q2 Earnings Snapshot (Associated Press)
  • Guardian Pharmacy Services Inc (GRDN) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
  • Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.3300.3150.290371.07365.767
2026Q22026-08-060.2900.2620.343351.77340.456
2026Q12026-05-060.2900.2400.209336.6329.896
2025Q42026-03-110.3700.2680.329397.62390.044
2025Q32025-11-100.2500.2350.155377.43354.154
2025Q22025-08-110.2300.1930.143344.33331.333
2025Q12025-05-120.1500.2200.150329.31321.212
2024Q42025-03-260.1900.2200.189338.57332.773
2024Q32024-11-130.2750.192-1.927314.39303.132
2024Q22024-08-280.240-0.168300.02--
2026Q4--0.454--392.887
2027Q1--0.290--362.035
2027Q2--0.338--376.485
2027Q3--0.386--395.145
2027Q4--0.488--418.125
2028Q1--0.350--397.271

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY-1.7700.193-1.7391,2281,223
2025FY1.0700.9830.7801,4491,441
2026FY-1.364--1,452
2027FY-1.496--1,551
2028FY-1.673--1,699

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-06750392.88390.9396.66
2026Q4S2026-11-05700387.78384.15393
2026Q4S2026-10-21700387.78384.15393
2026Q4S2026-09-21740387.78384.15393
2026Q4S2026-08-07640386.91384.15389.27
2026Q4S2026-07-21600378.45374.5382.13
2026Q4S2026-05-26602378.45374.5382.13
2026Q4S2026-05-08613378.45374.5382.13
2026Q4S2026-05-07623378.98374.5382.13
2026Q4S2026-04-27621381.35374.6386.22
2026Q4S2026-03-28521380.38374.6384.59
2026Q4S2026-03-27522380.38374.6384.59
2026Q4S2026-03-12422379.33374.6383.67
2026Q4S2026-01-21403376.93373.36380.9

Estimate history

EPS, annual0.2630.570.385-1.7390.7781.1725
Period20212022202320242025TTM
EPS, quarterly-1.9270.1890.150.1430.1550.3290.2090.3430.292
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual792.072908.9091046.1931228.4091448.6851457.05
Period20212022202320242025TTM
Sales, quarterly314.393338.569329.308344.334377.427397.616336.595351.768371.07
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual62.09462.09462.09463.28763.32163.342
Period20212022202320242025MRQ
Shares, quarterly63.29463.28763.28763.29763.32163.32163.32163.33263.342
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Total Revenue1,457.051,448.681,228.411,046.19908.91792.07
Cost of Goods Sold Incl. D&A1,129.971,166.64993.45846.54730.50638.14
Gross Profit327.08282.04234.96199.65178.40153.93
Selling, General and Administrative Excl. Other234.76193.13297.88158.71126.41123.78
Other Operating Expense0.000.000.000.000.000.00
Operating Income92.3288.91-62.9240.9551.9930.15
Interest Expense0.650.673.282.861.931.64
Unusual Expense-1.8216.210.000.000.000.00
Net Income Before Taxes105.1673.42-66.4837.7249.6628.33
Income Taxes29.1124.464.560.000.000.00
Consolidated Net Income76.0548.96-71.0337.7249.6628.33
Net Income From Continuing Operations74.7749.22-110.0523.9035.4216.31
Net Income74.7749.22-110.0523.9035.4216.31
EPS (Recurring)1.150.96-1.740.380.570.26
EPS (Basic, Before Extraordinaries)1.180.79-1.740.380.570.26
EPS (Diluted)1.170.78-1.740.380.570.26
EBITDA115.78111.25-43.1559.1868.5546.68
Non-Operating Income (Expense)11.661.39-0.28-0.37-0.40-0.19
Other After Tax Adjustments0.000.000.000.000.000.00
Stock Option Compensation Expense6.8010.94103.88-6.09-3.3813.03
Price To Earnings Ratio42.5242.52----
Price To Sales Ratio1.791.311.04---
Gross Margin22.4519.4719.1319.0819.6319.43
Operating Margin6.346.14-5.123.915.723.81
Net Margin5.133.40-8.962.283.902.06
Shares Outstanding63.3463.3263.2962.0962.0962.09
Market Capitalization3,158.193,158.191,282.341,283.61--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue371.07351.77336.60397.62377.43344.33329.31338.57
Cost of Goods Sold Incl. D&A285.85271.72260.29312.11302.71276.19264.96271.46
Gross Profit85.2280.0476.3185.5074.7268.1564.3567.10
Selling, General and Administrative Excl. Other59.7467.4858.6348.9157.8955.5751.3450.35
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income25.4812.5617.6836.6016.8312.5813.0116.75
Interest Expense0.180.150.150.160.160.170.170.42
Unusual Expense0.42-8.080.005.830.47-0.000.00
Net Income Before Taxes25.9829.7918.2931.1016.6312.5913.1116.22
Income Taxes6.867.674.759.837.043.763.834.38
Consolidated Net Income19.1222.1213.5421.279.598.839.2711.84
Net Income From Continuing Operations18.6821.8713.2920.929.829.039.4511.94
Net Income18.6821.8713.2920.929.829.039.4511.94
EPS (Recurring)0.300.250.210.390.160.140.150.19
EPS (Basic, Before Extraordinaries)0.290.350.210.330.160.150.150.19
EPS (Diluted)0.290.340.210.330.150.140.150.19
EBITDA31.4118.3723.6542.3422.6618.0718.2721.91
Non-Operating Income (Expense)1.099.300.770.500.440.180.27-0.11
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.162.321.470.853.443.513.132.73
Price To Earnings Ratio42.5250.1348.4947.27----
Price To Sales Ratio1.791.831.651.321.201.021.041.04
Gross Margin22.9722.7522.6721.5019.8019.7919.5419.82
Operating Margin6.873.575.259.204.463.653.954.95
Net Margin5.036.223.955.262.602.622.873.53
Shares Outstanding63.3463.3363.3263.3263.3263.3063.2963.29
Market Capitalization3,158.192,651.232,384.651,905.321,660.281,379.331,345.491,282.34

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY
Cash & Short Term Investments65.624.660.750.6115.01
Short Term Receivables101.6197.1577.2667.8355.25
Inventories43.3640.5536.7341.4433.09
Other Current Assets11.049.6214.8610.128.52
Total Current Assets221.63151.99129.60120.00111.87
Net Property, Plant & Equipment90.1778.9673.1865.1951.72
Total Investments and Advances0.000.000.000.000.00
Intangible Assets98.2284.2168.0370.4971.72
Deferred Tax Assets20.3219.76---
Other Assets0.440.380.360.430.53
Total Assets430.78335.30271.17256.11235.85
Short Term Debt Incl. Current Port. of LT Debt11.0310.6223.1216.3411.93
Accounts Payable116.21102.4285.6078.1064.62
Other Current Liabilities33.4731.0829.2917.5634.99
Total Current Liabilities160.70144.12138.01112.00111.54
Long Term Debt33.6926.7145.1346.6443.11
Provision for Risks Charges0.000.000.000.000.00
Deferred Tax Liabilities18.1214.49---
Other Liabilities0.340.0028.1621.5427.88
Total Liabilities212.85185.32211.31180.19182.53
Non-Equity Reserves0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00
Common Equity205.76142.6728.2142.7323.93
Total Shareholders Equity205.76142.6728.2142.7323.93
Accumulated Minority Interest12.167.3031.6533.2029.39
Total Equity217.92149.9859.8675.9353.32
Total Liabilities & Stockholders Equity430.78335.30271.17256.11235.85
Book Value Per Share3.252.250.450.690.39
Tangible Book Value Per Share1.700.92-0.64-0.45-0.77
Full-Time Employees3,6003,400---
Price to Book Ratio11.8210.0510.06--
Return on Assets12.85-36.299.0714.40-
Return on Equity28.25-128.8067.39106.28-
Return on Invested Capital20.55-64.9732.5939.6324.34
Quick Ratio1.110.770.670.700.71
Current Ratio1.381.050.941.071.00

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Net Income76.0548.96-71.0337.7249.6628.33
Depreciation23.4622.3419.7718.2316.5616.53
Other Funds (Non Cash)14.5619.51138.63-0.741.0215.11
Funds from Operations116.0293.8787.3755.2267.2459.97
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.966.38-29.4115.60-18.72-1.47
Cash from Operating Activities114.06100.2557.9670.8248.5258.50
Capital Expenditures-17.89-19.55-16.37-14.56-16.77-9.28
Net Assets From Acquisitions-7.54-13.42-14.71-0.98-2.00-4.40
Sale of Fixed Assets and Businesses1.531.970.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.760.740.672.100.870.54
Cash from Investing Activities-23.14-30.25-30.41-13.44-17.90-13.15
Cash Dividends Paid0.000.00-90.93-38.42-30.80-17.36
Change in Capital Stock0.00-1.59115.630.000.000.00
Repurchase of Common Pref Stock-30.28-29.040.000.000.000.00
Sale of Common Pref Stock30.2827.45115.630.000.000.00
Proceedsfrom Stock Options30.2827.45115.630.000.000.00
Issuance or Reduction of Debt, Net-4.30-4.98-36.48-2.89-2.80-6.10
Change in Long Term Debt-4.30-4.98-27.48-7.89-6.80-6.10
Issuance of Long Term Debt0.000.0015.000.000.000.00
Reduction of Long Term Debt-4.30-4.98-42.48-7.89-6.80-6.10
Net Financing Active Other Cash Flow-3.45-2.47-11.87-15.92-11.42-13.34
Other Financing Activities Uses-4.02-2.97-14.62-16.81-12.19-15.06
Cash from Financing Activities-7.75-9.04-23.64-57.23-45.03-36.79
Net Change in Cash83.1760.963.910.14-14.408.56
Free Cash Flow96.1780.7141.5956.2631.7549.22
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Price to Free Cash Flow27.1023.60----
Deferred Taxes & Investment Tax Credit-3.070.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments119.6689.8164.8965.6236.4918.82
Short Term Receivables107.68103.77111.70101.61106.1994.12
Inventories57.0550.4447.1643.3647.8644.16
Other Current Assets10.4310.6511.4311.047.7513.36
Total Current Assets294.82254.67235.18221.63198.28170.46
Net Property, Plant & Equipment90.2088.8990.8990.1788.3286.46
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets102.8096.3697.2298.2298.4893.75
Deferred Tax Assets2.622.202.2020.324.565.27
Other Assets1.351.461.450.440.390.39
Total Assets491.78443.58426.94430.78390.04356.33
Short Term Debt Incl. Current Port. of LT Debt7.637.387.2211.036.727.18
Accounts Payable126.31108.21108.55116.21121.67104.99
Other Current Liabilities45.1538.4644.7733.4733.5631.82
Total Current Liabilities179.09154.04160.54160.70161.95143.99
Long Term Debt27.9627.8629.6633.6927.3726.52
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---18.12--
Other Liabilities5.004.034.310.345.226.16
Total Liabilities212.06185.94194.52212.85194.54176.66
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity267.24245.61220.89205.76183.76169.56
Total Shareholders Equity267.24245.61220.89205.76183.76169.56
Accumulated Minority Interest12.4812.0311.5312.1611.7410.11
Total Equity279.72257.64232.42217.92195.50179.67
Total Liabilities & Stockholders Equity491.78443.58426.94430.78390.04356.33
Book Value Per Share4.223.883.493.252.902.68
Tangible Book Value Per Share2.602.361.951.701.351.20
Full-Time Employees---3,600--
Price to Book Ratio11.8212.0011.5910.379.798.64
Return on Assets16.9616.4813.9512.8510.90-27.69
Return on Equity33.1631.7528.1528.2525.85-97.70
Return on Invested Capital6.338.005.318.744.654.61
Quick Ratio1.331.331.171.110.930.88
Current Ratio1.651.651.461.381.221.18

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income19.1222.1213.5421.279.598.83
Depreciation5.935.815.985.745.845.49
Other Funds (Non Cash)3.854.832.843.045.726.03
Funds from Operations28.4832.7622.3632.4121.8620.34
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital14.89-2.74-16.302.196.31-0.41
Cash from Operating Activities43.3730.026.0634.6028.1719.94
Capital Expenditures-4.03-4.62-5.02-4.23-5.21-4.31
Net Assets From Acquisitions-7.040.000.00-0.49-4.00-8.92
Sale of Fixed Assets and Businesses0.530.300.350.350.391.09
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.170.580.000.010.240.22
Cash from Investing Activities-10.38-3.73-4.67-4.36-8.58-11.91
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.00-0.06
Repurchase of Common Pref Stock0.000.00-30.280.00-29.040.00
Sale of Common Pref Stock0.000.0030.280.0029.04-0.06
Proceedsfrom Stock Options0.000.0030.280.0029.04-0.06
Issuance or Reduction of Debt, Net-1.06-1.04-1.12-1.09-1.61-1.14
Change in Long Term Debt-1.06-1.04-1.12-1.09-1.61-1.14
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-1.06-1.04-1.12-1.09-1.61-1.14
Net Financing Active Other Cash Flow-2.09-0.34-1.00-0.02-0.31-2.00
Other Financing Activities Uses-2.01-0.49-1.00-0.52-0.31-2.00
Cash from Financing Activities-3.15-1.38-2.12-1.11-1.92-3.21
Net Change in Cash29.8524.91-0.7329.1317.674.82
Free Cash Flow39.3425.411.0430.3722.9615.63
Price to Free Cash Flow27.1033.5034.2623.7224.30-

Revenue breakdown

Retail-Drug Stores and Proprietary Stores2024: 1.23B 2025: 1.45B
United States2024: 1.23B 2025: 1.45B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3010.46%2.2M21.1M493.49K
2026-10-1511.31%2.4M21.1M485.83K
2026-09-3011.77%2.5M21.1M477.49K
2026-09-157.80%2.4M31.1M436.89K
2026-08-319.77%3.0M31.1M392.53K
2026-08-149.66%3.0M31.1M406.88K
2026-07-319.16%2.9M31.1M411.20K
2026-07-158.97%2.8M31.1M418.11K
2026-06-309.93%3.1M31.1M448.99K
2026-06-1513.42%3.2M24.2M482.00K
2026-05-2912.04%2.9M24.2M480.90K
2026-05-1511.44%2.8M24.2M445.84K
2026-04-3011.14%2.7M24.2M407.80K
2026-04-1514.30%2.5M17.6M398.84K
2026-03-3112.61%2.9M23.1M357.53K
2026-03-138.71%2.0M22.5M261.28K
2026-02-277.98%1.8M22.5M246.96K
2026-02-138.33%1.9M22.5M276.53K
2026-01-308.16%1.8M22.5M308.84K
2026-01-156.87%1.5M22.5M314.33K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call25.0023.2027.300.004.5650.000.000.938-0.1920.010
call30.0018.2022.300.003.5240.000.000.920-0.1830.012
call35.0013.2017.306.262.7360.000.000.897-0.1700.014
call40.008.2011.408.221.66027.000.000.803-0.2590.022
call45.003.406.202.700.9193.000.000.724-0.2240.026
call50.000.403.100.620.9722.000.000.538-0.1830.031
call55.000.002.200.000.9070.000.000.244-0.1230.024
call60.000.002.150.001.4080.000.000.214-0.1760.023
call65.000.002.150.001.5690.000.000.184-0.1750.022
call70.000.002.150.001.9990.000.000.167-0.2140.019
put25.000.002.150.004.1360.000.00-0.087-0.2730.013
put30.000.000.950.002.7600.000.00-0.080-0.1790.012
put35.000.000.950.002.1000.000.00-0.104-0.1650.014
put40.000.002.150.001.8610.000.00-0.190-0.2090.022
put45.000.002.300.001.4850.000.00-0.280-0.2170.026
put50.000.153.400.001.1170.000.00-0.458-0.1780.031
put55.003.606.800.001.2350.000.00-0.640-0.2030.029
put60.008.6011.800.001.6890.000.00-0.704-0.2470.027
put65.0013.6016.800.002.0270.000.00-0.741-0.2820.026
put70.0018.6021.800.002.3580.000.00-0.764-0.3080.024

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-05SCHEDULE 13G/ASEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-28SCHEDULE 13D/ASEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-27SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-06-228-KCurrent report2026-06-22SEC
2026-05-288-KCurrent report2026-05-21SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-05SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-05SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-05SEC
2026-05-078-KCurrent report2026-05-05SEC
2026-05-06S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-0300419.26M9
2026-020000
2026-010000
2025-1299.79K100
2025-110000

Institutional holders

Manager% owned
FMR LLC5.22%
WELLINGTON MANAGEMENT GROUP LLP2.73%
BlackRock, Inc.2.49%
VANGUARD CAPITAL MANAGEMENT LLC2.18%
Woodline Partners LP2.06%
Valiant Capital Management, L.P.1.87%
T. Rowe Price Investment Management, Inc.1.76%
FRANKLIN RESOURCES INC1.53%
GEODE CAPITAL MANAGEMENT, LLC1.50%
LOOMIS SAYLES & CO L P1.37%

Funds

Fund% owned
Fidelity Stock Selector Small Cap Fund0.85%
Putnam Core Equity Fund0.80%
Fidelity Small Cap Growth Fund0.75%
iShares Russell 2000 ETF0.75%
Loomis Sayles Small Cap Growth Fund0.74%
Fidelity Series Small Cap Opportunities Fund0.49%
AST Small-Cap Equity Portfolio0.46%
Brown Advisory Small-Cap Fundamental Value Fund0.44%
Fidelity Small Cap Stock Fund0.39%
Fidelity Small Cap Growth K6 Fund0.38%

OakChart. GRDN. Cached 15 minutes.